Publications (230 - 239)

239. Lorig-Roach, N.; Hamkins-Indik,F.; Johnson, T.A.; Tenney, K.;  Valeriote, F.A.; Crews, P. The potential of achiral sponge-derived and synthetic bromoindoles as selective cytotoxins against PANC-1 tumor cells. Tetrahedron 2018, 74, 217-223.

238. Zhang, H.; Dong, M.; Chen, J.; Wang, H.; Tenney, K.; Crews, P. Bioactive secondary metabolites from the marine sponge genus Agelas. Mar. Drugs 2017, 15, issue: 11 Article Number: 351.

237. McCauley, E.P.; Lam, H.; Lorig-Roach, N.L.; Luu, J.; Lloyd, C.; Tenney, K.; Pietraszkiewicz, H.; Diaz, C.; Valeriote, F.A.; Auerbuch, V.; Crews, P. An investigation of the physical and bioactive properties of bromo- and iodo-containing sponge derived compounds possessing an oxyphenylethanamine core. J. Nat. Prod. 2017, 80, 2256-2267.

236. Fraley, A.E.; Garcia-Borràs, M; Tripathi, A.; Khare, D.; Mercado-Marin, E. V.; Tran, H.; Dan, Q.; Webb, G.P.; Watts, K. R.; Crews, P.; Sarpong, R.; Williams, R. M.; Smith, J.L.; Houk, K. N.; Sherman, D.H. Function and structure of MalA/MalA', iterative halogenases for late-stage C-H functionalization of indole alkaloids. J. Am. Chem. Soc. 2017, 139, 12060-12068. DOI: 10.1021/jacs.7b06773.

235. Lorig-Roach, N.; Still, P.C.; Coppage, D.; Compton, J.E.; Crews, M.S.; Navarro, G.; Tenney, K.; Crews, P. Evaluating nitrogen-containing biosynthetic products produced by saltwater culturing of several California littoral zone Gram-negative bacteria. J. Nat. Prod. 2017, 80, 2304-2310. DOI:10.1021/ acs.jnatprod.7b00302 PMID:28777571.   .

234. Lin S.; McCauley, E. P.; Lorig-Roach, N.; Karen T.; Naphen, C. N.; Yang, A.-M.; Johnson, T. A. Hernadez, T.; Rattan, R.; Valeriote, F. A.; Crews, P. Another Look at Pyrroloiminoquinone Alkaloids—Perspectives on Their Therapeutic Potential from Known Structures and Semisynthetic Analogues Mar. Drugs 2017, 15, Issue: 4, Article Number: 98 doi:10.3390/md15040098 PMC Pending.

233. White, K. N.; Tenney, K.; Crews, P. The Bengamides: A Mini-Review of Natural Sources, Analogues,

Biological Properties, Biosynthetic Origins, and Future Prospects. J. Nat. Prod. 2017, 80, 740−755 DOI: 10.1021/acs.jnatprod.6b00970 PMCID# PMC5368688

232. Zhang, H.; Dong, M.; Wang H.; Crews, P. Secondary Metabolites from the Marine Sponge Genus Phyllospongia. Mar. Drugs 2017, 15, issue 1, Article No. 12; doi:10.3390/md15010012 PMC Pending.

231. Zhang, H.; Crews, P.; Tenney, K.; Valeriote, F.A.; Cytotoxic Phyllolactone Analogs from the Marine Sponge Phyllospongia papyrecea. Med. Chem. 2017 13. 295-300 PMID:27748180; PMCID 5384874.

230. Johnson, T. A.; Milan-Lobo, L.; Che, T.; Ferwerda, M.; Lambu, E.; McIntosh, N. L.; Li, F.; He, L.; Lorig-Roach, N.; Crews, P.; Whistler, J. L. Identification of the first marine-derived opioid receptor “balanced” agonist with a signaling profile that resembles the endorphins. ACS Chem. Neurosci. 2017, 8, 473–485 PMID: 27744679; PMC Pending.